Guiyang Xintian Pharmaceutical Co Ltd (002873) — Capital Reinvestment Ratio
Guiyang Xintian Pharmaceutical Co Ltd (002873) has a Capital Reinvestment Ratio of 0.19x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥48.81 Million) in capital expenditures (CN¥9.40 Million). See 002873 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Guiyang Xintian Pharmaceutical Co Ltd Capital Reinvestment Ratio (2012–2025)
This chart tracks Guiyang Xintian Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 14 annual periods.
Annual Capital Reinvestment Ratio for Guiyang Xintian Pharmaceutical Co Ltd (2012–2025)
Year-by-year Capital Reinvestment Ratio for Guiyang Xintian Pharmaceutical Co Ltd from 2012 to 2025. For live market cap and broader valuation context, see Guiyang Xintian Pharmaceutical Co Ltd market capitalisation.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.62x | CN¥83.73 Million | CN¥51.59 Million | ▼ -11.6% |
| 2024 | 0.70x | CN¥88.13 Million | CN¥61.45 Million | ▼ -46.7% |
| 2023 | 1.31x | CN¥77.78 Million | CN¥101.70 Million | ▼ -23.3% |
| 2022 | 1.70x | CN¥75.82 Million | CN¥129.20 Million | ▲ +100.4% |
| 2021 | 0.85x | CN¥124.30 Million | CN¥105.69 Million | ▲ +119.3% |
| 2020 | 0.39x | CN¥175.77 Million | CN¥68.15 Million | ▼ -91.6% |
| 2019 | 4.63x | CN¥33.73 Million | CN¥156.07 Million | ▲ +443.2% |
| 2018 | 0.85x | CN¥47.59 Million | CN¥40.54 Million | ▼ -49.8% |
| 2017 | 1.70x | CN¥62.06 Million | CN¥105.21 Million | ▲ +655.2% |
| 2016 | 0.22x | CN¥61.34 Million | CN¥13.77 Million | ▼ -72.8% |
| 2015 | 0.83x | CN¥40.73 Million | CN¥33.66 Million | ▼ -21.7% |
| 2014 | 1.06x | CN¥37.30 Million | CN¥39.38 Million | ▼ -59.1% |
| 2013 | 2.58x | CN¥13.88 Million | CN¥35.85 Million | ▲ +1.5% |
| 2012 | 2.54x | CN¥21.41 Million | CN¥54.47 Million | — |